MedTrace Logo

A Prospective Evaluation of Clinical Equivalence Between iX and PID

NCT03967405 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-03-06

No results posted yet for this study

Summary

Patients with chronic wounds will be imaged using 2 imaging devices. Two types of images will be acquired with each device, a standard photograph (ST-image) and a fluorescence image (FL-image). The images captured with the 2 imaging devices will be compared off-line by many interpreters to assess for any differences in the images that would alter a clinical decision.

Conditions

  • Wound

Interventions

DEVICE

MolecuLight PID

Hand-held, real-time fluorescence imaging device

Sponsors & Collaborators

  • MolecuLight Inc.

    lead INDUSTRY

Principal Investigators

  • Ronald Linden · Judy Dan Research and Treatment Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-03-15
Completion
2021-03-15
FDA Device
Yes

Countries

  • Canada

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967405 on ClinicalTrials.gov